Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals

Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer

(2009) T. deVos et al.   CLINICAL CHEMISTRY

Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer

(2008) E. Lindholm et al.   BRITISH JOURNAL OF SURGERY

Banking of Biological Fluids for Studies of Disease-associated Protein Biomarkers

(2008) Anne-Sofie Schrohl et al.   MOLECULAR & CELLULAR PROTEOMICS

Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay

(2008) Robert Grützmann et al.   PLoS One

Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment

(2008) Nanna Møller Sørensen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): A novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection

(2008) Hans Jørgen Nielsen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Dependence of TIMP-1 Plasma Levels on Preanalytical Specimen Handling

(2008) Marie Dresse et al.   TUMOR BIOLOGY